Evaluation of thiabendazole treatment for hookworm and ascaris infections.
D000293:Adolescent; D000328:Adult; D001196:Ascariasis / Q000188:drug therapy*; D002648:Child; D003085:Colic / Q000139:chemically induced; D005069:Evaluation Studies as Topic; D005260:Female; D006261:Headache / Q000139:chemically induced; D006725:Hookworm Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013827:Thiabendazole / Q000009:adverse effects / Q000627:therapeutic use*; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D013827:Thiabendazole